219 related articles for article (PubMed ID: 27703003)
1. SUMO Modification Reverses Inhibitory Effects of Smad Nuclear Interacting Protein-1 in TGF-β Responses.
Liu S; Long J; Yuan B; Zheng M; Xiao M; Xu J; Lin X; Feng XH
J Biol Chem; 2016 Nov; 291(47):24418-24430. PubMed ID: 27703003
[TBL] [Abstract][Full Text] [Related]
2. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
Lee PS; Chang C; Liu D; Derynck R
J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation enhances the activity of the TGF-β/SMAD and HIF-1 signaling pathways in keloids.
Lin X; Wang Y; Jiang Y; Xu M; Pang Q; Sun J; Yu Y; Shen Z; Lei R; Xu J
Life Sci; 2020 Aug; 255():117859. PubMed ID: 32474020
[TBL] [Abstract][Full Text] [Related]
4. A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction.
Kim RH; Wang D; Tsang M; Martin J; Huff C; de Caestecker MP; Parks WT; Meng X; Lechleider RJ; Wang T; Roberts AB
Genes Dev; 2000 Jul; 14(13):1605-16. PubMed ID: 10887155
[TBL] [Abstract][Full Text] [Related]
5. Activation of transforming growth factor-beta signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4.
Lin X; Liang M; Liang YY; Brunicardi FC; Melchior F; Feng XH
J Biol Chem; 2003 May; 278(21):18714-9. PubMed ID: 12621041
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta-independent regulation of myogenesis by SnoN sumoylation.
Wrighton KH; Liang M; Bryan B; Luo K; Liu M; Feng XH; Lin X
J Biol Chem; 2007 Mar; 282(9):6517-24. PubMed ID: 17202138
[TBL] [Abstract][Full Text] [Related]
7. Small ubiquitin-like modifier (SUMO) modification of zinc finger protein 131 potentiates its negative effect on estrogen signaling.
Oh Y; Chung KC
J Biol Chem; 2012 May; 287(21):17517-17529. PubMed ID: 22467880
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta-mediated signaling via the p38 MAP kinase pathway activates Smad-dependent transcription through SUMO-1 modification of Smad4.
Ohshima T; Shimotohno K
J Biol Chem; 2003 Dec; 278(51):50833-42. PubMed ID: 14514699
[TBL] [Abstract][Full Text] [Related]
9. Sumoylated SnoN represses transcription in a promoter-specific manner.
Hsu YH; Sarker KP; Pot I; Chan A; Netherton SJ; Bonni S
J Biol Chem; 2006 Nov; 281(44):33008-18. PubMed ID: 16966324
[TBL] [Abstract][Full Text] [Related]
10. SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4.
Lin X; Liang M; Liang YY; Brunicardi FC; Feng XH
J Biol Chem; 2003 Aug; 278(33):31043-8. PubMed ID: 12813045
[TBL] [Abstract][Full Text] [Related]
11. The type I TGF-beta receptor is covalently modified and regulated by sumoylation.
Kang JS; Saunier EF; Akhurst RJ; Derynck R
Nat Cell Biol; 2008 Jun; 10(6):654-64. PubMed ID: 18469808
[TBL] [Abstract][Full Text] [Related]
12. PIASy-mediated sumoylation of SREBP1c regulates hepatic lipid metabolism upon fasting signaling.
Lee GY; Jang H; Lee JH; Huh JY; Choi S; Chung J; Kim JB
Mol Cell Biol; 2014 Mar; 34(6):926-38. PubMed ID: 24379443
[TBL] [Abstract][Full Text] [Related]
13. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.
Imoto S; Sugiyama K; Muromoto R; Sato N; Yamamoto T; Matsuda T
J Biol Chem; 2003 Sep; 278(36):34253-8. PubMed ID: 12815042
[TBL] [Abstract][Full Text] [Related]
14. Pli1(PIAS1) SUMO ligase protected by the nuclear pore-associated SUMO protease Ulp1SENP1/2.
Nie M; Boddy MN
J Biol Chem; 2015 Sep; 290(37):22678-85. PubMed ID: 26221037
[TBL] [Abstract][Full Text] [Related]
15. PIASxα ligase enhances SUMO1 modification of PTEN protein as a SUMO E3 ligase.
Wang W; Chen Y; Wang S; Hu N; Cao Z; Wang W; Tong T; Zhang X
J Biol Chem; 2014 Feb; 289(6):3217-30. PubMed ID: 24344134
[TBL] [Abstract][Full Text] [Related]
16. Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility.
Li C; McManus FP; Plutoni C; Pascariu CM; Nelson T; Alberici Delsin LE; Emery G; Thibault P
Nat Commun; 2020 Feb; 11(1):834. PubMed ID: 32047143
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation and SUMO-interacting motif (SIM) of metastasis tumor antigen 1 (MTA1) synergistically regulate its transcriptional repressor function.
Cong L; Pakala SB; Ohshiro K; Li DQ; Kumar R
J Biol Chem; 2011 Dec; 286(51):43793-43808. PubMed ID: 21965678
[TBL] [Abstract][Full Text] [Related]
18. Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein.
Sundvall M; Korhonen A; Vaparanta K; Anckar J; Halkilahti K; Salah Z; Aqeilan RI; Palvimo JJ; Sistonen L; Elenius K
J Biol Chem; 2012 Jun; 287(27):23216-26. PubMed ID: 22584572
[TBL] [Abstract][Full Text] [Related]
19. Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-beta signaling.
Imoto S; Ohbayashi N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T
Biochem Biophys Res Commun; 2008 May; 370(2):359-65. PubMed ID: 18384750
[TBL] [Abstract][Full Text] [Related]
20. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
